Internal Hemorrhoids
8
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
38%
3 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Clinical Outcomes After Laser Hemorrhoidoplasty
Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation
Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)
HELO Trial: Energy-Based Therapies vs. Conventional Hemorrhoidectomy for Grade III Hemorrhoids
Evaluate Safety and Efficacy of 25 mg Hydrocortisone Acetate Suppositories in Treatment of Internal Hemorrhoids
Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids
Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids
Study About Patient Comfort and Long-term Outcome After Stapled Hemorrhoidopexy